BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 32847857)

  • 21. Inflammatory tumour cell killing by oncolytic reovirus for the treatment of melanoma.
    Errington F; White CL; Twigger KR; Rose A; Scott K; Steele L; Ilett LJ; Prestwich R; Pandha HS; Coffey M; Selby P; Vile R; Harrington KJ; Melcher AA
    Gene Ther; 2008 Sep; 15(18):1257-70. PubMed ID: 18401435
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mesenchymal stem cells loaded with oncolytic reovirus enhances antitumor activity in mice models of colorectal cancer.
    Babaei A; Soleimanjahi H; Soleimani M; Arefian E
    Biochem Pharmacol; 2021 Aug; 190():114644. PubMed ID: 34090878
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oncolytic reovirus-mediated killing of mouse cancer-associated fibroblasts.
    Kurisu N; Kaminade T; Eguchi M; Ishigami I; Mizuguchi H; Sakurai F
    Int J Pharm; 2021 Dec; 610():121269. PubMed ID: 34748806
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oncolytic reovirus induces intracellular redistribution of Ras to promote apoptosis and progeny virus release.
    Garant KA; Shmulevitz M; Pan L; Daigle RM; Ahn DG; Gujar SA; Lee PW
    Oncogene; 2016 Feb; 35(6):771-82. PubMed ID: 25961930
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The use of immunohistochemistry to determine oncolytic reovirus distribution and replication in-human tumors.
    Kapadia R; Coffey MC
    Methods; 2010 Dec; 52(4):301-6. PubMed ID: 20801221
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reovirus Efficiently Reassorts Genome Segments during Coinfection and Superinfection.
    Thoner TW; Meloy MM; Long JM; Diller JR; Slaughter JC; Ogden KM
    J Virol; 2022 Sep; 96(18):e0091022. PubMed ID: 36094315
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mesenchymal stem cells support delivery and boost the efficacy of oncolytic reoviruses in TC-1 tumor cells.
    Banijamali RS; Soleimanjahi H; Soudi S; Karimi H
    J Cell Biochem; 2021 Oct; 122(10):1360-1375. PubMed ID: 34056765
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reovirus and tumor oncolysis.
    Kim M; Chung YH; Johnston RN
    J Microbiol; 2007 Jun; 45(3):187-92. PubMed ID: 17618222
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serotype-Specific Killing of Large Cell Carcinoma Cells by Reovirus.
    Simon EJ; Howells MA; Stuart JD; Boehme KW
    Viruses; 2017 Jun; 9(6):. PubMed ID: 28587298
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potential for Improving Potency and Specificity of Reovirus Oncolysis with Next-Generation Reovirus Variants.
    Mohamed A; Johnston RN; Shmulevitz M
    Viruses; 2015 Dec; 7(12):6251-78. PubMed ID: 26633466
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reovirus infection activates JNK and the JNK-dependent transcription factor c-Jun.
    Clarke P; Meintzer SM; Widmann C; Johnson GL; Tyler KL
    J Virol; 2001 Dec; 75(23):11275-83. PubMed ID: 11689607
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PUMA and NF-kB Are Cell Signaling Predictors of Reovirus Oncolysis of Breast Cancer.
    Thirukkumaran C; Shi ZQ; Thirukkumaran P; Luider J; Kopciuk K; Spurrell J; Elzinga K; Morris D
    PLoS One; 2017; 12(1):e0168233. PubMed ID: 28099441
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Strategic Combinations: The Future of Oncolytic Virotherapy with Reovirus.
    Zhao X; Chester C; Rajasekaran N; He Z; Kohrt HE
    Mol Cancer Ther; 2016 May; 15(5):767-73. PubMed ID: 27197256
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of a replicating expanded tropism oncolytic reovirus carrying the adenovirus E4orf4 gene.
    Kemp V; Dautzenberg IJC; Cramer SJ; Hoeben RC; van den Wollenberg DJM
    Gene Ther; 2018 Aug; 25(5):331-344. PubMed ID: 30013187
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-tumour activity of oncolytic reovirus against canine histiocytic sarcoma cells.
    Igase M; Shousu K; Fujiki N; Sakurai M; Bonkobara M; Hwang CC; Coffey M; Noguchi S; Nemoto Y; Mizuno T
    Vet Comp Oncol; 2019 Jun; 17(2):184-193. PubMed ID: 30761736
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of oncolytic reovirus in canine lymphoma cell lines.
    Hwang CC; Umeki S; Igase M; Coffey M; Noguchi S; Okuda M; Mizuno T
    Vet Comp Oncol; 2016 Aug; 14 Suppl 1():61-73. PubMed ID: 25319493
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cell Entry-Independent Role for the Reovirus μ1 Protein in Regulating Necroptosis and the Accumulation of Viral Gene Products.
    Roebke KE; Danthi P
    J Virol; 2019 Jun; 93(11):. PubMed ID: 30894465
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Breast Tumor-Associated Metalloproteases Restrict Reovirus Oncolysis by Cleaving the σ1 Cell Attachment Protein and Can Be Overcome by Mutation of σ1.
    Fernandes JP; Cristi F; Eaton HE; Chen P; Haeflinger S; Bernard I; Hitt MM; Shmulevitz M
    J Virol; 2019 Nov; 93(22):. PubMed ID: 31462562
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oncolytic activity of reovirus in HPV positive and negative head and neck squamous cell carcinoma.
    Cooper T; Biron VL; Fast D; Tam R; Carey T; Shmulevitz M; Seikaly H
    J Otolaryngol Head Neck Surg; 2015 Feb; 44(1):8. PubMed ID: 25890191
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anticancer efficiency of reovirus in normoxia and hypoxia.
    Figová K; Hraběta J; Eckschlager T
    Folia Biol (Praha); 2013; 59(2):68-75. PubMed ID: 23746172
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.